In re Hypodermic Products Antitrust Litigation
Court: United States District Court for the District of New Jersey
Case No.: MDL No. 1730
Wexler Wallace serves as co-lead class counsel on behalf of hospitals, pharmacies and other purchasers of hypodermic products manufactured by Becton Dickinson. The Plaintiffs allege that Becton maintained a monopoly in the disposable hypodermic products market by “bundling” products to reduce or eliminate competition in one of the “bundled” product markets. As a result, healthcare providers and others paid more for these Becton products than they should have paid for the anti-competitive monopoly.
The hypodermic products at issue in the litigation include items such as disposable syringes and associated needles, disposable blood collection tubes and holders, IV catheter devices, and their associated needles.
To view the most recent Complaint, click here.
This case had two sets of Plaintiffs claiming the right to sue under the federal antitrust laws: (1) the Distributor Plaintiffs (wholesalers) and (2) the Healthcare Plaintiffs, consisting of hospitals and other healthcare providers. Wexler Wallace represents the Healthcare Plaintiffs. Both sets of Plaintiffs allege that Defendant engaged in anticompetitive practices with respect to sales of disposable syringes and associated needles, disposable blood collection tubes and holders, IV catheter devices and their associated needles.
The Healthcare Plaintiffs received final approval of a $22 million class settlement on March 17, 2014. To visit the settlement website and view court documents, visit www.hypodermicproductsantitrustlitigation.com.